CP101 for the Treatment of Ulcerative Colitis

NCT05852574 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: CP-101
DRUG: CP-101 + Placebo

Sponsor

Brigham and Women's Hospital